Research finds no vasectomy reversal link to prostate cancer

April 19, 2018, Curtin University

New Curtin University research that studied almost 10,000 men who had undergone vasectomy reversals across the globe has found no evidence of a link between the procedure and prostate cancer.

The paper, published in the Journal of Urology, studied the population health data of 684,660 men with vasectomies living in Australia, Canada and the United Kingdom, including 9,754 men who had undergone vasectomy reversals.

Lead author Dr. Sean Randall, from the Centre for Data Linkage at Curtin University, said previous evidence on the link between a vasectomy and prostate cancer had been conflicting.

"The link between vasectomy and prostate cancer has been debated for many years after two studies from the early 1990s showed an elevated risk of prostate cancer in men who had undergone vasectomies," Dr. Randall said.

"Our research studied the theory that if a vasectomy is considered a cause of prostate cancer then should hypothetically decrease the risk of prostate cancer. However, our analysis of almost 10,000 vasectomy reversals found no link between the procedure and prostate cancer at all."

Dr. Randall said the research indicated there was no clinically meaningful relationship between men who had had vasectomies and the rate of prostate cancer.

"Our research therefore shows that the risk of prostate should not rate as a factor for men who are weighing up the decision of whether or not to have a vasectomy," Dr. Randall said.

"This study supports previous that found little or no evidence of any link between vasectomies and ."

As part of this study, researchers examined 1015 vasectomy reversals and 55,416 vasectomies from Western Australia, 2440 reversals and 58,503 vasectomies in New South Wales, 88 reversals and 37,133 vasectomies in Wales, 2227 reversals and 159,089 vasectomies in Scotland, and 3984 reversals and 374,519 vasectomies in Ontario. The time periods assessed ranged from 1972 to 2016.

Explore further: 'March madness' a peak time for vasectomies

More information: Sean Randall et al. The Effect of Vasectomy Reversal on Prostate Cancer Risk: International Meta-Analysis of 684,660 Men with Vasectomies, The Journal of Urology (2018). DOI: 10.1016/j.juro.2018.03.005

Related Stories

'March madness' a peak time for vasectomies

March 16, 2018
(HealthDay)—Thinking about a vasectomy? Now—as March Madness begins—might be just the time for the procedure.

Vasectomy may increase risk of aggressive prostate cancer

July 9, 2014
Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). The researchers found ...

Vasectomy may not raise prostate cancer risk after all

September 20, 2016
(HealthDay)—A large, new study challenges previous research that suggested vasectomies might increase the risk of prostate cancer or dying from it.

Little evidence that vasectomy raises prostate cancer risk

July 18, 2017
(HealthDay)—For men who have had or might undergo a vasectomy, there is good news: A major study finds scant evidence that the procedure raises their risk of prostate cancer.

Vasectomy reversal outcomes up with same partner as before

January 9, 2015
(HealthDay)—Fertility outcomes are improved for men who undergo vasectomy reversal and have the same female partner as before vasectomy, according to a study published in the January issue of The Journal of Urology.

Risk factors for prostate cancer

September 30, 2015
New research suggests that age, race and family history are the biggest risk factors for a man to develop prostate cancer, although high blood pressure, high cholesterol, vitamin D deficiency, inflammation of prostate, and ...

Recommended for you

Scientists reveal likely cause of childhood leukaemia

May 21, 2018
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.

Compound in citrus oil could reduce dry mouth in head, neck cancer patients

May 21, 2018
A compound found in citrus oils could help alleviate dry mouth caused by radiation therapy in head and neck cancer patients, according to a new study by researchers at the Stanford University School of Medicine.

Ice cream funds research showing new strategy against thyroid cancer

May 21, 2018
Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis. And standard treatment for the condition includes 7 weeks of radiation, often along with chemotherapy.

Bladder cancer model could pave the way for better drug efficacy studies

May 21, 2018
Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients ...

MR spectroscopy imaging reveals effects of targeted treatment of mutant IDH1 gliomas

May 18, 2018
Using a novel imaging method, a Massachusetts General Hospital (MGH) research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas. In their report ...

Particle shows promise to prevent the spread of triple-negative breast cancer

May 18, 2018
USC researchers have pinpointed a remedy to prevent the spread of triple-negative breast cancer. Metastatic breast cancer is a leading cause of death for women. The findings appear today in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.